اکنون در دسترس! پژوهش تلگرام ۲۰۲۵ — مهمترین بینشهای سال 
Pharmacology
رفتن به کانال در Telegram
Contact admin @murtazakuchay for any Queries/promotion/copyright issue
نمایش بیشتر📈 تحلیل کانال تلگرام Pharmacology
کانال Pharmacology (@pharma_vid) در بخش زبانی انگلیسی بازیگری فعال است. در حال حاضر جامعه شامل 64 409 مشترک است و جایگاه 219 را در دسته پزشکی و رتبه 5 417 را در منطقه الهند دارد.
📊 شاخصهای مخاطب و پویایی
از زمان ایجاد در невідомо، پروژه رشد سریعی داشته و 64 409 مشترک جذب کرده است.
بر اساس آخرین دادهها در تاریخ 05 ژوئن, 2026، کانال فعالیت پایداری دارد. در ۳۰ روز گذشته تغییر اعضا برابر -499 و در ۲۴ ساعت گذشته برابر -3 بوده و همچنان دسترسی گستردهای حفظ شده است.
- وضعیت تأیید: تأیید نشده
- نرخ تعامل (ER): میانگین تعامل مخاطب 11.05% است و در ۲۴ ساعت نخست پس از انتشار، محتوا معمولاً 4.76% واکنش نسبت به کل مشترکان کسب میکند.
- دسترسی پستها: هر پست به طور میانگین 7 120 بازدید دریافت میکند. در اولین روز معمولاً 3 066 بازدید جمعآوری میشود.
- واکنشها و تعامل: مخاطبان بهطور فعال حمایت میکنند؛ میانگین واکنش به هر پست 11 است.
- علایق موضوعی: محتوا بر موضوعات کلیدی مانند drug, i.e., dose, treatment, cisplatin تمرکز دارد.
📝 توضیح و سیاست محتوایی
نویسنده این فضا را محل بیان دیدگاههای شخصی توصیف میکند:
“Contact admin @murtazakuchay for any Queries/promotion/copyright issue”
به لطف بهروزرسانیهای پرتکرار (آخرین داده در تاریخ 06 ژوئن, 2026)، کانال همواره بهروز و دارای دسترسی بالاست. تحلیلها نشان میدهد مخاطبان بهطور فعال با محتوا تعامل دارند و آن را به نقطه اثرگذاری مهم در دسته پزشکی تبدیل کردهاند.
64 409
مشترکین
-324 ساعت
-1157 روز
-49930 روز
آرشیو پست ها
64 409
Central Drug Standard Control Organisation (CDSCO) regulates the clinical trials and approval of investigational new drugs in India.
The proposal for initiating trials, review of clinical trial results and recommendations for marketing authorization is done through a committee called Investigational New Drug (IND) Committee formed by CDSCO.
Preclinical trials are performed on animals, and they are regulated by guidelines prescribed by the Committee for the Purpose of the Control and Supervision of Experiments on Animals (CPCSEA) in India.
64 409
Inverse agonists are druas which have an affinity for a receptor, but the intrinsic activity opposite to that of an agonist. ◦ IA of an inverse agonist is between 0 and -1
The ability of the drug to bind with a receptor is called affinity. ◦ The capacity of a drug to induce a functional change in the receptor is called intrinsic activity or efficacy.
64 409
A true statement regarding inverse agonist is that it
#NEET PG #INICET #FMGE #PYQ
64 409
Join PROFWISE MBBS Groups!
1. 1st PROF MBBS: https://t.me/+rMA2Sew_gp41MDk1
2. 2nd PROF MBBS: https://t.me/+SD0oh2UMHAFmNjM1
3. 3rd PROF MBBS: https://t.me/+yxj_Ruzm37o0MDY1
4. FINAL PROF MBBS: https://t.me/+WQnwlzhiBU1hMTc1
5. FMGE (Abroad MBBS): https://t.me/FMGEgroupstudents
6. NEET PG/INICET (Interns/Post-interns): https://t.me/+TfvNbL3UWlw1NWI1
7. NEET SS/INI SS (Residents): https://t.me/Neet_SS
Join respective group only! ⚠️
Queries: https://t.me/murtazakuchay (@murtazakuchay) 💬
64 409
*PrepLadder Version XI Launch*
🎯 _No Miss Deal Of Year 2026_
*Register for Offer* 👉: https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ
Till Neet PG Plan- *₹7899*
12 months *17499*
16 months *21499*
24 months *25499*
36 months *30999*
48 months *34999*
☮️ Use Best Code: *DCTRXNSQ*
*Register Offer Link* : https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ
Max Discount: *DCTRXNSQ*
*Join whatsApp* : https://chat.whatsapp.com/FdIInMlLAOeFl2kvg2xhT8?mode=gi_t
64 409
Prepladder XI Early Bird Offer is valid only until April 16! 📅
Get the Elite Pack for NEET PG for only Rs 7,499 🎓.
12-month pack for only Rs 17,499 🗓️.
Best code for an additional discount: *DCTRNXSQ* 💰
https://www.prepladder.com/app/isa-bd-code--DCTRXNSQ 🔗
https://prepladder.com/app/inspire-event-395--DCTRXNSQ
For any queries regarding more offers, inbox: 💬
http://wa.me/919469334046 📱
64 409
EARLY BOOKING LIVE NOW! 🚀
HIGHEST DISCOUNT ON PREPLADDER XI
+ CHANCE TO WIN FREE iPHONE🎁
Use Code: DCTRNXSQ
https://prepladder.com/app/inspire-event-395--DCTRXNSQ
JOIN OUR WHATSAPP GROUP for early Group Offer
https://chat.whatsapp.com/FdIInMlLAOeFl2kvg2xhT8?mode=gi_t
64 409
Win IPHONE 17 & MacBook for FREE
📢 _The Most Awaited Medical Event Of The Year 2026_ is here! 🩺✨
*Register Now*: https://prepladder.com/app/inspire-event-395--DCTRXNSQ
🎥 *PrepLadder INSPIRE*
📅 *When:* 12th April 2026 | 🕛 *12 PM onwards*
📍 *Where:* Live on YouTube ▶️
🔥 *What’s in store?*
- 🚀 _Version XI Grand Launch_
- 🤫 _Exclusive Reveals & Expert Insights_
- 🎁 _Chance to win iPhone 17 & Macbook more!_
⏳ Don’t miss out!
https://prepladder.com/app/inspire-event-395--DCTRXNSQ
👆 *REGISTER NOW* 👆
Share link with your squad 🫂 Let’s gooo! 🔔💙
64 409
FREE PREPLADDER RAPID REVISION
For the next 3 days free access, you can step inside *Rapid Revision*
*Click on the link below to register FREE 🆓👇*
https://prepladder.com/app/rapid-revision-XI-videos-391--DCTRXNSQ
Max Discount code: *
DCTRXNSQ*
⚡ High-yield video lectures
⚡ Every topic tagged with PYQs from NEET PG, FMGE & INI-CET
😱 *DON'T FORGET TO CLICK THE LINK FOR FREE ACCESS* 👇
https://prepladder.com/app/rapid-revision-XI-videos-391--DCTRXNSQ
Best discount code: *DCTRXNSQ*
_This is your chance to experience Rapid Revision before the real deal begins_64 409
☮️Version XI Prepladder Early Bird Offer is Live 😍😍
🎯Yes, It's Live Dear Dr. 👨⚕
Click on the link below for the best discount👇
https://prepladder.com/app/version-vxi-offers-389--DCTRXNSQ
🤩 Get max discount price in EBO ++ get much early access to Version XI than others
https://prepladder.com/app/version-vxi-offers-389--DCTRXNSQ
Best discount code: DCTRXNSQ
Max Discount code: DCTRXNSQ
Don't wait, You won't get this opportunity and offer again.
For best offer join: https://chat.whatsapp.com/FdIInMlLAOeFl2kvg2xhT8?mode=gi_t
64 409
FREE PREPLADDER for 3 days
*🔥TRY EVERYTHING. RISK NOTHING!🔥*
*_⚠️Get Full PrepLadder ELITE access for 3 DAYS_*
*👉Activate for just ₹11😍*
*🎯 Best chance to experience ELITE before committing*
⏳Click the link given below To Activate now & start serious prep today!
Link: https://prepladder.com/app/free-trial-redirect-386--DCTRXNSQ
Contact: http://wa.me/919469334046
64 409
+1
🔥Resolve Live Classes batch NEETPG
Starts 31st January 2026
For Free live session on 31st Jan,2026 register 👇below
https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ
Use Best Code: DCTRXNSQ
Register now for free Live class 👇
https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ
📚 Full 19-subject coverage
📄 PDFs for every class
📝 19 subject tests + discussion sessions (TnD)
🕒 24×7 educator support
📊 4 full mock tests
👨🏫 Mentorship from top educators
🔗 Access to ELITE Plan assets
Offer Valid for all NEETPG/FMGE, SS, Residency, Pro. & Proff Packs as well.
🔆Use Maximum Discount code: DCTRXNSQ
64 409
Correct Answer - A
Ans: A. Thiazide increases the tubular absorption of lithium
Drug Interaction:
Diuretics + Lithium = Decreased excretion—rise in Li + level -
toxicity;
Diuretics (thiazide, furosemide) by causing Na + loss to promote
proximal tubular reabsorption of Na + as well as Li + → plasma
levels of lithium rise. Potassium-sparing diuretics cause milder Li +
retention.
Management: Reduce dose of lithium and monitor level.
64 409
A patient on lithium therapy developed
hypertension. He was started on Thiazide
for hypertension. After a few days, he developed coarse tremors and other symptoms suggestive of lithium toxicity. What is the probable mechanism of interaction?
64 409
+1
🥳Happy New Year, With A Bang 💥
30% , Yes you heard it right 30% + ₹1500 Offer is live
Discount code for Prepladder any plan: DCTRXNSQ
Use Code: DCTRXNSQ
To buy any Package Apply Code directly in Prepladder app or click on the link 👇
https://www.prepladder.com/app/isa-bd-code--DCTRXNSQ
inbox for any queries
http://wa.me/919469334046
64 409
Correct Answer - C
Ans: C. Chronic tophaceous gout
Pegloticase:
Pegloticase is a medication for the treatment of the severe,
treatment of refractory chronic gout.
It is a third-line treatment in those in whom other treatments are not
tolerated.
64 409
Pegloticase is used for the treatment of
an Ankylosing spondylosis
